CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020		14,572,650
Beginning balance at Dec. 31, 2020	$ 144,126	$ 1	$ 167,052	$ (22,549)	$ (378)
Increase (Decrease) in Stockholders' Deficit
Issuance of shares (in shares)		520,375
Issuance of shares	39,012	$ 1	39,011
Share-based compensation expense	434		434
Net loss	(4,903)			(4,903)
Ending balance (in shares) at Mar. 31, 2021		15,093,025
Ending balance at Mar. 31, 2021	178,669	$ 2	206,497	(27,452)	(378)
Beginning balance (in shares) at Dec. 31, 2020		14,572,650
Beginning balance at Dec. 31, 2020	144,126	$ 1	167,052	(22,549)	(378)
Increase (Decrease) in Stockholders' Deficit
Net loss	(24,158)
Currency translation adjustments	0
Ending balance (in shares) at Sep. 30, 2021		15,093,025
Ending balance at Sep. 30, 2021	160,580	$ 2	207,662	(46,706)	(378)
Beginning balance (in shares) at Mar. 31, 2021		15,093,025
Beginning balance at Mar. 31, 2021	178,669	$ 2	206,497	(27,452)	(378)
Increase (Decrease) in Stockholders' Deficit
Share-based compensation expense	568		568
Net loss	(7,676)			(7,676)
Ending balance (in shares) at Jun. 30, 2021		15,093,025
Ending balance at Jun. 30, 2021	171,561	$ 2	207,065	(35,128)	(378)
Increase (Decrease) in Stockholders' Deficit
Share-based compensation expense	597		597
Net loss	(11,578)			(11,578)
Currency translation adjustments	0
Ending balance (in shares) at Sep. 30, 2021		15,093,025
Ending balance at Sep. 30, 2021	$ 160,580	$ 2	207,662	(46,706)	(378)
Beginning balance (in shares) at Dec. 31, 2021	18,946,567	18,946,567
Beginning balance at Dec. 31, 2021	$ 266,923	$ 2	331,074	(62,606)	(1,547)
Increase (Decrease) in Stockholders' Deficit
Share-based compensation expense	812		812
Net loss	(16,318)			(16,318)
Currency translation adjustments	(1,230)				(1,230)
Ending balance (in shares) at Mar. 31, 2022		18,946,567
Ending balance at Mar. 31, 2022	$ 250,187	$ 2	331,886	(78,924)	(2,777)
Beginning balance (in shares) at Dec. 31, 2021	18,946,567	18,946,567
Beginning balance at Dec. 31, 2021	$ 266,923	$ 2	331,074	(62,606)	(1,547)
Increase (Decrease) in Stockholders' Deficit
Net loss	(96,052)
Currency translation adjustments	$ (14,655)
Ending balance (in shares) at Sep. 30, 2022	23,877,828	23,877,828
Ending balance at Sep. 30, 2022	$ 131,898	$ 2	306,756	(158,658)	(16,202)
Beginning balance (in shares) at Mar. 31, 2022		18,946,567
Beginning balance at Mar. 31, 2022	250,187	$ 2	331,886	(78,924)	(2,777)
Increase (Decrease) in Stockholders' Deficit
Issuance of shares (in shares)		463,610
Issuance of shares	2,381		2,381
Issuance of earn-out shares	(31,026)		(31,026)
Share-based compensation expense	7,985		7,985
Net loss	(78,655)			(78,655)
Currency translation adjustments	(9,291)				(9,291)
Recapitalization transaction (in shares)		1,967,651
Recapitalization transaction	(5,400)		(5,400)
Ending balance (in shares) at Jun. 30, 2022		21,377,828
Ending balance at Jun. 30, 2022	136,181	$ 2	305,826	(157,579)	(12,068)
Increase (Decrease) in Stockholders' Deficit
Issuance of shares (in shares)		2,300,000
Issuance of shares	0
Exercise of pre-funded warrants (in shares)		200,000
Exercise of pre-funded warrants	390		390
Share-based compensation expense	540		540
Net loss	(1,079)			(1,079)
Currency translation adjustments	$ (4,134)				(4,134)
Ending balance (in shares) at Sep. 30, 2022	23,877,828	23,877,828
Ending balance at Sep. 30, 2022	$ 131,898	$ 2	$ 306,756	$ (158,658)	$ (16,202)